UK markets close in 54 minutes

Chugai Pharmaceutical Co., Ltd. (CHGCY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
20.93+0.13 (+0.63%)
As of 10:20AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 68.73B
Enterprise value 64.61B
Trailing P/E 30.06
Forward P/E 29.59
PEG ratio (5-yr expected) 10.13
Price/sales (ttm)7.93
Price/book (mrq)6.59
Enterprise value/revenue 0.05
Enterprise value/EBITDA 0.14

Trading information

Stock price history

Beta (5Y monthly) 0.48
52-week change 368.56%
S&P500 52-week change 328.71%
52-week high 321.60
52-week low 311.93
50-day moving average 318.91
200-day moving average 316.06

Share statistics

Avg vol (3-month) 376.31k
Avg vol (10-day) 3120.01k
Shares outstanding 53.29B
Implied shares outstanding 63.3B
Float 8639.37M
% held by insiders 10.00%
% held by institutions 10.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.29
Forward annual dividend yield 41.41%
Trailing annual dividend rate 380.00
Trailing annual dividend yield 3384.62%
5-year average dividend yield 41.62
Payout ratio 438.69%
Dividend date 316 Sept 2019
Ex-dividend date 429 Jun 2023
Last split factor 212:1
Last split date 306 Jul 2020

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 29.29%
Operating margin (ttm)44.34%

Management effectiveness

Return on assets (ttm)14.44%
Return on equity (ttm)21.34%

Income statement

Revenue (ttm)1.11T
Revenue per share (ttm)337.76
Quarterly revenue growth (yoy)-37.60%
Gross profit (ttm)N/A
EBITDA 466.09B
Net income avi to common (ttm)325.47B
Diluted EPS (ttm)0.69
Quarterly earnings growth (yoy)-11.00%

Balance sheet

Total cash (mrq)738.98B
Total cash per share (mrq)449.14
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.74
Book value per share (mrq)988.01

Cash flow statement

Operating cash flow (ttm)409.92B
Levered free cash flow (ttm)317.92B